Companhia Brasileira De Distribuicao (CBD)’s financial ratios: A comprehensive overview

After finishing at $3.36 in the prior trading day, Companhia Brasileira De Distribuicao (NYSE: CBD) closed at $3.32, down -1.19%. In other words, the price has decreased by -$0.0400 from its previous closing price. On the day, 529981 shares were traded. CBD stock price reached its highest trading level at $3.3800 during the session, while it also had its lowest trading level at $3.3200.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



Our goal is to gain a better understanding of CBD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.70. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.66.

Upgrades & Downgrades

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CBD now has a Market Capitalization of 813.90M and an Enterprise Value of 2.05B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 0.08. Its current Enterprise Value per Revenue stands at 0.11 whereas that against EBITDA is 1.29.

Stock Price History:

Over the past 52 weeks, CBD has reached a high of $4.43, while it has fallen to a 52-week low of $2.54. The 50-Day Moving Average of the stock is 3.0246, while the 200-Day Moving Average is calculated to be 3.4656.

Shares Statistics:

The stock has traded on average 1.32M shares per day over the past 3-months and 752.11k shares per day over the last 10 days, according to various share statistics. A total of 269.98M shares are outstanding, with a floating share count of 158.93M. Insiders hold about 57.40% of the company’s shares, while institutions hold 5.80% stake in the company. Shares short for CBD as of Apr 27, 2023 were 2.23M with a Short Ratio of 2.23M, compared to 2.98M on Mar 30, 2023.

Dividends & Splits

In the trailing 12 months, CBD’s forward annual dividend rate was 0.00, compared to 0.07 this year. The stock’s 5-year Average Dividend Yield is 3.03.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of $0.01 for the current quarter, with a high estimate of $0.01 and a low estimate of $0.01, while EPS last year was $0.53. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.

Analysts are recommending an EPS of between $0.17 and -$0.31 for the fiscal current year, implying an average EPS of -$0.07. EPS for the following year is -$0.47, with 2 analysts recommending between -$0.44 and -$0.5.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for CBD’s current fiscal year. The highest revenue estimate was $8.21B, while the lowest revenue estimate was $8.21B, resulting in an average revenue estimate of $8.21B. In the same quarter a year ago, actual revenue was $9.5B, down -13.60% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $3.85B in the next fiscal year. The high estimate is $3.85B and the low estimate is $3.85B. The average revenue growth estimate for next year is down -53.10% from the average revenue estimate for this year.